Bio-Rad Laboratories, Inc. Press Releases

BIO 
$150.7
*  
0.11
0.07%
Get BIO Alerts
*Delayed - data as of Jul. 31, 2015 15:22 ET  -  Find a broker to begin trading BIO now
Exchange: NYSE
Industry: Capital Goods
Community Rating:
View:    BIO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Bio-Rad Announces U.S. FDA Pre-Market Approval for the BioPlex 2200 HIV Ag-Ab Assay, a Novel Next Generation HIV Diagnostic Test
7/28/2015 4:15:00 PM - Market Wire
▲0.84 % Price Change since this news event. The Volume Ratio is 0.89.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Bio-Rad to Report Second-Quarter 2015 Financial Results Thursday, August 6, 2015
7/10/2015 4:28:00 PM - Market Wire
▲1.84 % Price Change since this news event. The Volume Ratio is 0.97.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Bio-Rad Announces FDA Clearance for Diagnosing Diabetes With Its VARIANT II TURBO HbA1c Kit - 2.0
6/9/2015 4:27:00 PM - Market Wire
▲2.10 % Price Change since this news event. The Volume Ratio is 1.64.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Bio-Rad Reports First-Quarter 2015 Financial Results
5/5/2015 4:15:00 PM - Market Wire